Roche suffers a fresh blow as India’s Supreme Court allows generic sales of its pricey rare disease drug Natco Pharma can start selling a less expensive drug to combat spinal muscular atrophy

https://www.statnews.com/pharmalot/2025/10/19/india-supreme-court-roche-evrysdi-generic-natco-sma/